7th December 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

*Refresh the page if the below document does not appear.

Cadila pharma to establish pharma formulation manufacturing facility in Odisha

Cadila Pharmaceuticals has signed an Investment Intention Form (IIF) with the Government of Odisha to establish a pharma formulation manufacturing facility under the Odisha Government’s newly devised Industrial policy, 2022.

Madras High Court stays NGT order against Sun Pharmaceuticals

On Tuesday, Madras high court stayed the order of National Green Tribunal (NGT) imposing an interim compensation of

Rs 10 crore on Sun Pharma for expanding its drug manufacturing facility in Maduranthagam allegedly without required environmental clearance from the concerned authority.

Natco Pharma's crop care solutions likely to facilitate stock growth

Natco Pharma’s stocks observed gains that rose more than 3% in the intraday trades on Tuesday before closing 0.7% higher on the bourses. This happened after Natco Pharma received a favourable judgement from the Delhi High Court in a case of patent infringement.

GSK, Sanofi, Takeda along with Singapore researchers plan to boost Biologics Innovation

Pharma majors like GSK, Sanofi, and Takeda are planning to partner with research communities from the agency of Science Technology and Research, the National University of Singapore, and two more leading institutions to give a push to Singapore’s Biologics manufacturing capabilities.

Eli Lilly files FDA application to expand its Breast Cancer drug Verzenio’s use

Drugmaker Eli Lilly has filed an FDA application to expand the use of Verzenio in HR-positive, HER2-negative early breast cancer which has a high risk of recurrence after surgery to include patients with low levels of the cellular proliferation marker Ki-67.

US Judge dismisses lawsuits for Zantac over invalid scientific evidence for Cancer cases

US District Judge Robin Rosenberg stated that consumers used wrong scientific evidence to file lawsuits against the heartburn drug Zantac, claiming it to cause a variety of cancers. The judge found that experts couldn’t find any relation between the drug and the diseases.

Digital upskilling has become crucial for the pharma sector

Due to the pandemic, the dynamics of the industry changed and like all other industries pharma also while searching the antidote for the virus had to shift to home and develop digital processes and skills like automation and data analytics.

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Update profile

Please update your profile to keep using the website

Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?